Rationale for Prolonged Corticosteroid Treatment in the Acute Respiratory Distress Syndrome Caused by Coronavirus Disease 2019

Critical Care Explorations

Volumn 2, Issue 4, 2020, Pages E0111-

  Villar, Jesús ^a,b,c   Confalonieri, Marco ^d   Pastores, Stephen M ^e   Umberto Meduri, G ^f,g  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF TRIESTE   (Italy)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

acute respiratory distress syndrome; coronavirus disease 2019; corticosteroids; intensive care unit; mechanical ventilation; mortality

Indexed keywords

EID: 85087801077     PISSN: None     EISSN: 26398028     Source Type: Journal    
DOI: 10.1097/CCE.0000000000000111     Document Type: Note

References (28)

1. Chen N, Zhou M, Dong X,. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020; 395: 507-513
2. Huang C, Wang Y, Li X,. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395: 497-506
3. Wu C, Chen X, Cai Y,. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020. Mar 13. [online ahead of print]
4. Ashbaugh DG, Maier RV,. Idiopathic pulmonary fibrosis in adult respiratory distress syndrome. Diagnosis and treatment. Arch Surg. 1985; 120: 530-535
5. Annane D, Pastores SM, Rochwerg B,. Guidelines for the diagnosis and management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Crit Care Med. 2017; 45: 2078-2088
6. Villar J, Ferrando C, Martínez D, dexamethasone in ARDS network. Dexamethasone treatment for the acute respiratory distress syndrome: A multicentre, randomised controlled trial. Lancet Respir Med. 2020; 8: 267-276
7. Meduri GU, Bridges L, Shih MC,. Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: Analysis of individual patients' data from four randomized trials and trial-level meta-analysis of the updated literature. Intensive Care Med. 2016; 42: 829-840
8. Confalonieri M, Urbino R, Potena A,. Hydrocortisone infusion for severe community-acquired pneumonia: A preliminary randomized study. Am J Respir Crit Care Med. 2005; 171: 242-248
9. Tongyoo S, Permpikul C, Mongkolpun W,. Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: Results of a randomized controlled trial. Crit Care. 2016; 20: 329
10. Meduri GU, Headley AS, Golden E,. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: A randomized controlled trial. JAMA. 1998; 280: 159-165
11. Steinberg KP, Hudson LD, Goodman RB, National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006; 354: 1671-1684
12. Meduri GU, Golden E, Freire AX,. Methylprednisolone infusion in early severe ARDS: Results of a randomized controlled trial. Chest. 2007; 131: 954-963
13. Mehta P, McAuley DF, Brown M,. COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet. 2020; 395: 1033-1034
14. Meduri GU, Annane D, Chrousos GP,. Activation and regulation of systemic inflammation in ARDS: Rationale for prolonged glucocorticoid therapy. Chest. 2009; 136: 1631-1643
15. Tang L, Zhang X, Wang Y,. Severe COVID-19 pneumonia: Assessing inflammation burden with volume-rendered chest CT. Radiology: Cardiothoracic Imaging. 2020; 2: e200044
16. Xu Z, Shi L, Wang Y,. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020; 8: 420-422
17. World Health Organization: Coronavirus Disease 2019 (COVID-19): Situation Report-54. Available at: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200314-sitrep-54-covid-19.pdf1. Accessed March 14, 2020
18. Arabi YM, Mandourah Y, Al-Hameed F,. Corticosteroid therapy for critically ill patients with the Middle East Respiratory Syndrome. Am J Respir Crit Care Med. 2018; 197: 757-767
19. Delaney JW, Pinto R, Long J,. The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09)-related critical illness. Crit Care. 2016; 20: 75
20. Lansbury LE, Rodrigo C, Leonardi-Bee J,. Corticosteroids as adjunctive therapy in the treatment of influenza: An updated cochrane systematic review and meta-analysis. Crit Care Med. 2020; 48: e98-e106
21. Russell CD, Millar JE, Baillie JK,. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020; 395: 473-475
22. Shang L, Zhao J, Hu Y,. On the use of corticosteroids for 2019-nCoV pneumonia. Lancet. 2020; 395: 683-684
23. Ni YN, Chen G, Sun J,. The effect of corticosteroids on mortality of patients with influenza pneumonia: A systematic review and meta-analysis. Crit Care. 2019; 23: 99
24. Long Y, Xu Y, Wang B,. Clinical recommendations from an observational study on MERS: Glucocorticoids was benefit in treating SARS patients. Int J Clin Exp Med. 2016; 9: 8865-8873
25. Li H, Yang SG, Gu L, National Influenza A(H1N1)pdm09 Clinical Investigation Group of China. Effect of low-to-moderate-dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1)pdm09 viral pneumonia. Influenza Other Respir Viruses. 2017; 11: 345-354
26. Nicastri E, Petrosillo N, Bartoli TA,. National institute for the infectious diseases "L. Spallanzani" IRCCS. Recommendations for COVID-19 clinical management. Infect Dis Rep. 2020; 12: 8543
27. Chen RC, Tang XP, Tan SY,. Treatment of severe acute respiratory syndrome with glucosteroids: The Guangzhou experience. Chest. 2006; 129: 1441-1452
28. Meduri GU, Bridges L, Siemieniuk RAC,. An exploratory reanalysis of the randomized trial on efficacy of corticosteroids as rescue therapy for the late phase of acute respiratory distress syndrome. Crit Care Med. 2018; 46: 884-891